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Abstract
AviMatrix® (benzoic acid, calcium formate and fumaric acid) is intended to be used as a zootechnical
additive (functional group: other zootechnical additives) in feed of chickens for fattening, chickens
reared for laying, minor avian species for fattening and minor avian species reared to point of lay to
increase performance. The additive has not been authorised in the EU. In 2014, the EFSA Panel on
Additives and Products or Substances used in Animal Feed (FEEDAP) adopted an opinion in which,
owing to insufﬁcient tolerance data and the limited and inconsistent evidence of efﬁcacy, a deﬁnitive
conclusion on the safety and efﬁcacy of the additive as a zootechnical additive could not be drawn.
Additional data have been provided by the applicant related to the safety and the efﬁcacy of the
additive for the target species, which is the subject of this opinion. The FEEDAP Panel considers that the
additive is tolerated by chickens for fattening up to the maximum recommended dose (1,000 mg/kg
complete feed); this conclusion can be extended to chickens reared for laying. However, since no
conclusion could be drawn on the margin of safety, the safety of the additive to minor avian species for
fattening and to point of lay cannot be extrapolated. Data from three trials provided evidence that
AviMatrix® at 500 mg/kg complete feed had the potential to improve the performance of chickens for
fattening. The dose proposed for use with chickens reared for laying and minor poultry species for
fattening and to point of lay is the same as that demonstrated being efﬁcacious in a physiologically
similar major species (chickens for fattening) and it can be reasonably assumed that the mode of action
is the same. Consequently, the conclusion on efﬁcacy for chickens for fattening can be extended to
chickens reared for laying and extrapolated to minor poultry species for fattening and to point of lay.
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1. Introduction
1.1. Background and Terms of Reference as provided by the European
Commission
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition and in particular, Article 9 deﬁnes the terms of such authorisation
by the Commission.
The applicant Novus Europe SA is seeking a Community authorisation of a preparation of benzoic acid,
calcium formate and fumaric acid to be used as zootechnical additive for chickens for fattening, chickens
reared for laying, minor avian species for fattening and minor avian species to point of lay (Table 1).
On 2 July 2014, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
of the European Food Safety Authority (EFSA) (‘Authority’), in its opinion on the safety and efﬁcacy of
the product, concluded that limited and inconsistent evidence of efﬁcacy and insufﬁcient tolerance data
had been provided, so the FEEDAP Panel was not in a position to draw a deﬁnitive conclusion on the
safety and efﬁcacy of the additive.
The Commission gave the possibility to the applicant to submit complementary information in order
to complete the assessment and allow a revision of the Authority’s opinion. The new data have been
received on 28 November 2016.
In view of the above, the Commission asks the Authority to deliver a new opinion of AviMatrix®
(benzoic acid, calcium formate and fumaric acid) as a zootechnical additive for chickens for fattening,
chickens reared for laying, minor avian species for fattening and minor avian species to point of lay
based on the additional data submitted by the applicant.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of additional
information2 to a previous application on the same product.3
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of AviMatrix® is
in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant guidance
documents: Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012), Technical guidance:
Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011).
3. Assessment
AviMatrix® is a granulated preparation of benzoic acid, calcium formate and fumaric acid encapsulated
in a lipid matrix. It is proposed to be used as a zootechnical additive (functional group: other zootechnical
additives) in chickens for fattening, chickens reared for laying, minor avian species for fattening and
minor avian species reared to point of lay, with the aim of affecting favourably their performance.
Table 1: Description of the substances
Category of additive Zootechnical additives
Functional group of additive Other zootechnical additives
Description Preparation of a lipid matrix containing benzoic acid, calcium formate
and fumaric acid
Target animal category Chickens for fattening, chickens reared for laying, minor avian species for
fattening and minor avian species to point of lay
Applicant Novus Europe SN.A./S.V.
Type of request New Opinion
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 FEED dossier reference: FAD-2017-0007.
3 FEED dossier reference: FAD-2012-0037.
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In the supplementary information dossier, the applicant proposes to express the speciﬁcations of
the additive in terms of minimum or maximum contents and not as a range as expressed in the
previous opinion (EFSA FEEDAP Panel, 2015).4 Therefore, the additive is speciﬁed to contain ≥ 42.5%
benzoic acid, ≥ 2.5% calcium formate, ≥ 0.8% fumaric acid and ≥ 45% palm stearin. It is also
proposed that silica or calcium carbonate can be used interchangeably as excipients, at a total
maximum level of 3%.5 The different way of expression of the speciﬁcation will not have implications
on the outcome of the previous assessment, as the product is the same, i.e. the results of the batch to
batch variation previously submitted match with the new format of speciﬁcation proposal. Similarly, it
is considered that the inclusion of calcium carbonate as an alternative excipient that can be used
replacing silica does not have an impact on either the safety or the efﬁcacy of the product.
The additive is intended to be used in feedingstuffs for chickens for fattening, chickens reared for
laying, minor avian species for fattening and minor avian species to point of lay at a recommended use
level ranging between 500 (minimum content) and 1,000 (maximum content) mg/kg complete feed.
The FEEDAP Panel notes that the applicant has modiﬁed the minimum content (formerly 250 mg
additive/kg complete feed) and recommends a maximum use level. Both proposals will be considered
in the context of the current assessment.
In its previous opinion, the FEEDAP Panel concluded that limited and inconsistent evidence of
efﬁcacy and insufﬁcient tolerance data had been provided, so the FEEDAP Panel was not in a position
to draw a deﬁnitive conclusion on the safety and efﬁcacy of the additive (EFSA FEEDAP Panel, 2015).
The applicant has submitted additional information related to the safety of the additive for the
target species and on the efﬁcacy of the additive and this new information is the subject of this
opinion.
3.1. Safety for the target species
In its previous assessment (EFSA FEEDAP Panel, 2015), the FEEDAP Panel was not in a position to
conclude on the safety of AviMatrix® for the target species considering the weakness of the tolerance
study (e.g. lack of clinical biochemistry and pathology data for the proposed recommended dose), the
increased feed-to-gain ratio with all doses of AviMatrix® and the statistically signiﬁcant differences in
some of the serum enzyme activities.
The applicant provided a new tolerance study to evaluate the safety of AviMatrix® in chickens for
fattening.6 A total of 1,800 1-day-old male Ross 308 chickens distributed into 45 ﬂoor pens of 40 birds
each were used. Chickens were fed a starter diet from day 1 until day 21 and a grower diet from day
22 until day 35, both based on wheat, maize and soybean meal, and presented in mash form.
AviMatrix® was incorporated into the basal diets at 0 (control), 250, 500, 1,000 or 3,000 mg/kg
complete feed, corresponding to 0-, 90.25-, 90.5-, 91- and 93-fold the maximum recommended
dose, respectively. Benzoic acid was analysed in all the diets to conﬁrm concentrations of additive in
feed. Therefore, there were ﬁve experimental treatments (levels of additive inclusion) with nine
replicates (pens) per treatment. Feed and water were available ad libitum over the experimental period
of 35 days. Body weight (BW) and feed intake (FI) were recorded on days 0, 21 and 35, and average
daily gain (ADG), average daily feed intake (ADFI) and feed-to-gain ratio were calculated. Mortality
was checked daily and the most probable cause of death and culling was recorded.
On day 35, 45 chickens (one per pen) were randomly selected for haematological7 and serum
biochemistry8 parameters. These 45 chickens were killed and examined for gross lesions in the oral
cavity, crop and intestinal tract. The experiment was laid out as a randomised block design and data
were subjected to analysis of variance considering the pen as the experimental unit. Statistical
signiﬁcances were declared at p < 0.05.
Overall mortality rate was low (< 3.5%) and was not treatment related. Performance parameters
were not adversely affected and no signiﬁcant differences between treatments were observed over the
whole experimental period. Across all the experimental treatments, average ﬁnal BW was 2.39 kg
4 Text from the previous EFSA Opinion (EFSA FEEDAP Panel, 2015): The additive is speciﬁed to contain 42.5–50% benzoic acid,
2.5–3.5% calcium formate, 0.8–1.2% fumaric acid, 3% precipitated silica and 45% palm stearin.
5 Technical dossier/Supplementary information November 2016/Annex A.
6 Technical dossier/Supplementary information November 2016/Avimatrix_Tolerance_broilers.pdf.
7 Red blood cell counts (RBC), reticulocyte count, mean corpuscular haemoglobin (MCH), mean corpuscular volume (MCV),
haemoglobin (Hb), haematocrit/packed cell volume (PCV), white blood cell counts (WBC) and white blood cell differentials
(basophils, heterophils, lymphocytes, monocytes, eosinophils).
8 Alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), glutamic oxalacetic transaminase (GOT), glutamic pyruvate
transaminase (GPT), lactate dehydrogenase (LDH), creatinine kinase (CK), glucose, uric acid, total protein, albumin.
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(range (2.37–2.42 kg), ADG 66.9 g/day (range 66.3–67.6 g/day), ADFI 102.6 g (range 101.8–103.5 g)
and feed-to-gain ratio 1.54 (range 1.53–1.56). No signiﬁcant effects of AviMatrix® supplementation
were observed in blood biochemistry and most haematological parameters. However, for some
haematological parameters, there were signiﬁcant (p < 0.05) differences between the control and the
93 dose treatments. Compared with the unsupplemented control, in the 93 level, the number of
leucocytes (15.3 vs 29.7 9 106/mL) and heterophils (5.5 vs 17.4 9 106/mL) were decreased, the
percentage of lymphocytes was increased (44% vs 27%) and the percentage of heterophils was
decreased (36% vs 57%). There was no evidence at necropsy that AviMatrix® exerted adverse effects
on the gastrointestinal tract.
The FEEDAP Panel notes that the ratio of neutrophils/lymphocytes was greater in the control group,
what may indicate a situation of stress (Davis et al., 2008) in these birds. If this was the case, the
haematological proﬁle would be less favourable in the control than in the overdosed treatment.
However, in the lack of reliable reference values, the Panel considers that the decrease in the number
of total leucocytes and heterophils in the 93 dose might be an adverse effect.
The FEEDAP Panel considers that the additive is tolerated by chickens for fattening up to the
maximum recommended dose (1,000 mg/kg complete feed). This conclusion can be extended to
chickens reared for laying. However, no conclusion can be drawn on the margin of safety given the
observed changes in the number of white blood cells at threefold overdose of AviMatrix®.
Consequently, the conclusion cannot be extrapolated to minor avian species for fattening and to point
of lay.
3.2. Efﬁcacy
3.2.1. Efﬁcacy for chickens for fattening
In its previous assessment (EFSA FEEDAP Panel, 2015), the Panel concluded that ‘only two studies
showed a positive effect of AviMatrix® supplementation on the performance of chickens for fattening.
In addition, because of the signiﬁcant treatment 9 study interactions, the results of the meta-analysis
cannot be used to assess the efﬁcacy of AviMatrix®. Therefore, the FEEDAP Panel is not in the position
to conclude on the efﬁcacy of AviMatrix® in chickens for fattening’.
The applicant provided an additional efﬁcacy study with chickens for fattening. A total of 1,100
one-day-old male Ross 308 chickens were into 50 pens of 22 birds each. The animals were fed a basal
wheat–barley–soybean meal diet supplemented with AviMatrix® at either 0 or 500 mg/kg feed. Each
treatment was applied to 25 pens (experimental units). Broilers were fed a starter diet (2,950 kcal ME/kg)
from day 1 until day 21 and a grower/ﬁnisher diet (3,050 kcal ME/kg) from day 22 until day 35. All feeds
were in mash form and offered ad libitum.
Body weight was recorded at 1, 21 and 35 days. Average daily weight gain and feed-to-gain ratio
were calculated for the periods 1–21, 22–35 and 1–35 days. Mortality, culling and the most probable
cause of mortality were recorded. Data were subjected to analysis of variance considering the pen as
the experimental unit. Statistical signiﬁcance was declared at p < 0.05.
Mortality was low (< 3%) and no treatment related. Supplementation with AviMatrix® resulted in a
signiﬁcant improvement (p < 0.05) in ﬁnal BW, ADG and feed-to-gain ratio over the whole study
period (Table 2). No differences were observed in the ADFI.
Results of the two positive studies (studies 1 and 2) assessed in the previous opinion together with
the newly submitted study (study 3) are shown in Table 2.
Table 2: Effects of AviMatrix® on the performance of chickens for fattening
Trial
(days)
AviMatrix®
(mg/kg
feed)
Total number of birds
(replicates/treatment
3 birds/replicate)
Sex
Final
weight
(kg)
Feed
intake
(kg/bird)
Feed-
to-gain
ratio
Mortality
(%)
1d (42) 0 1,600 (10 9 40) Male 2.51a 4.47a 1.82a 0.3
266 2.69b 4.65b 1.76b 0.3
532 2.79c 4.84c 1.76b 0.5
1,064 2.76bc 4.78bc 1.76b 1.5
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Considering the results of the current study, along with the two efﬁcacy studies already assessed in
the previous opinion (EFSA FEEDAP Panel, 2015), in which the performance of chickens for fattening
was positively affected as a result of the supplementation with the additive at 500 mg/kg complete
feed, the FEEDAP Panel concludes that AviMatrix® at 500 mg/kg complete feed has the potential to
improve the growth of chickens for fattening.
3.2.2. Conclusions on efﬁcacy
Data from three trials provide evidence that the inclusion of AviMatrix® at 500 mg/kg complete
feed has the potential to improve the performance of chickens for fattening.
The dose proposed for use with chickens reared for laying and minor poultry species for fattening
and to point of lay is the same as that demonstrated being efﬁcacious in a physiologically similar major
species (chickens for fattening) and it can be reasonably assumed that the mode of action is the same.
Consequently, the conclusion on efﬁcacy for chickens for fattening can be extended to chickens reared
for laying and extrapolated to minor poultry species for fattening and to point of lay without a need for
speciﬁc studies and when used at the same dose.
4. Conclusions
The FEEDAP Panel considers that the additive is tolerated by chickens for fattening up to the
maximum recommended dose (1,000 mg/kg complete feed). This conclusion can be extended to
chickens reared for laying. However, no conclusion can be drawn on the margin of safety given the
observed changes in the number of white blood cells at threefold overdose of AviMatrix®. Consequently,
the conclusion cannot be extrapolated to minor avian species for fattening and to point of lay.
Data from three trials provide evidence that the inclusion of AviMatrix® at 500 mg/kg complete
feed has the potential to improve the performance of chickens for fattening. The dose proposed for
use with chickens reared for laying and minor poultry species for fattening and to point of lay is the
same as that demonstrated being efﬁcacious in a physiologically similar major species (chickens for
fattening) and it can be reasonably assumed that the mode of action is the same. Consequently, the
conclusion on efﬁcacy for chickens for fattening can be extended to chickens reared for laying and
extrapolated to minor poultry species for fattening and to point of lay.
Documentation provided to EFSA
1) AviMatrix® (preparation of benzoic acid, calcium formate and fumaric acid) for chickens for
fattening, chickens reared for laying, minor avian species for fattening and to point of lay.
November 2016. Submitted by Novus Europe S.A.
2) AviMatrix® (preparation of benzoic acid, calcium formate and fumaric acid) for chickens for
fattening, chickens reared for laying, minor avian species for fattening and to point of lay.
January 2013. Submitted by Novus Europe S.A.
Trial
(days)
AviMatrix®
(mg/kg
feed)
Total number of birds
(replicates/treatment
3 birds/replicate)
Sex
Final
weight
(kg)
Feed
intake
(kg/bird)
Feed-
to-gain
ratio
Mortality
(%)
2e (42) 0 800 (10 9 20) Male 2.61 4.18 1.62a 2.0
250 2.66 4.24 1.62a 5.0
500 2.69 4.22 1.59b 4.5
1,000 2.66 4.20 1.60ab 4.0
3f (35) 0 1,100 (25 9 22) Male 2.19a 3.27 1.51a 1.6
500 2.26b 3.30 1.48b 2.7
a,b,c: Within each trial and column, values with no common superscript differ signiﬁcantly (p ≤ 0.05).
d: Technical dossier/Section IV/Annex_IV_3.1. (Dossier FAD-2012-0037).
e: Technical dossier/Section IV/Annex_IV_3.3. (Dossier FAD-2012-0037).
f: Technical dossier/Supplementary information November 2016/Avimatrix_Efﬁcacy_Broilers.
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ADFI average daily feed intake
ADG average daily gain
BW body weight
FEEDAP EFSA Panel on Additives and Products or Substances used in Animal Feed
FI feed intake
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